Esophageal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Esophageal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Clinical Trial to Evaluate the Safety and Effectiveness of TQB2618 Injection Combined Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and effectiveness of TQB2618 Injection Combined Therapy in advanced esophageal squamous cel…
-
CLINICAL_TRIALS other · 2025-07-16Clinical Trial Update: Adjuvant Immunotherapy for Esophageal Squamous Cell Carcinoma [NA]
An update for a clinical trial investigating adjuvant immunotherapy for Esophageal Squamous Cell Carcinoma indicates the study is not yet re…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors [Phase 1]
This Phase 1 trial reports on the safety, tolerability, pharmacokinetics, and pharmacodynamics of INCB099280 in participants with advanced s…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma
A City of Hope Medical Center-sponsored clinical trial is recruiting to develop methods for predicting early tumor recurrence in patients wi…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma
A recruiting clinical trial aims to predict the effectiveness of postoperative chemotherapy in patients with esophageal squamous cell carcin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
Clinical trial evaluating patient-derived organoids to observe the clinical consistency of personalized neoadjuvant therapy for resectable e…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma
A clinical trial studying early esophageal squamous cell carcinoma with lymph node metastasis is currently in recruitment, utilizing radiomi…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: QL1706 Plus Celecoxib in Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 trial is evaluating QL1706 in combination with Celecoxib for advanced esophageal squamous cell carcinoma; the study status is not …
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203) [Phase 2]
This is a Phase 2 master protocol evaluating SAR444245 in combination with other anticancer therapies for several gastrointestinal cancers; …
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating cardenilimab in combination with chemotherapy for locally advanced esophageal squamous cell carcinoma is…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical Study [Phase 1]
Phase I study evaluating definitive proton radiotherapy combined with chemotherapy and immunotherapy for locally advanced esophageal squamou…
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating sitravatinib plus tislelizumab in Esophageal Squamous Cell Carcinoma has been terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands [Phase 1]
Phase 1 clinical trial update of LGK974, a Wnt pathway inhibitor, in malignancies dependent on Wnt ligands; the study included several cance…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Study on Adjuvant Chemotherapy After Total Two-field Lymph Node Dissection of Thoracic Esophageal Squamous Cell Carcinoma [NA]
This clinical trial update notes that a study evaluating adjuvant chemotherapy after total two-field lymph node dissection for thoracic esop…
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous Carcinoma [Phase 2]
Phase 2 trial evaluating tislelizumab in combination with chemotherapy as perioperative treatment for esophageal squamous cell carcinoma; th…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Efficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC Patients [Phase 2]
A Phase 2 neoadjuvant trial evaluating the combination of sintilimab with nab-paclitaxel and cisplatin in BR-Esophageal Squamous Cell Carcin…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Immunochemotherapy ± Salvage Chemoradiation for Local Recurrence of Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy [Phase 3]
A Phase 3 clinical trial is evaluating immunochemotherapy with or without salvage chemoradiation for local recurrence of Esophageal Squamous…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101) [Phase 3]
Phase 3 trial evaluating a PD-1 inhibitor in combination with neoadjuvant chemoradiotherapy and surgery for locally advanced esophageal squa…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer [Phase 2]
A Phase 2 trial investigating neoadjuvant radiochemotherapy combined with cadonilizumab for locally advanced esophageal squamous cell carcin…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal Cancer [Phase 2]
A Phase 2 trial evaluating induction chemoimmunotherapy followed by concurrent radiotherapy for locally advanced esophageal squamous cell ca…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers [Phase 1]
Phase 1 trial updating on the addition of Adavosertib to radiation therapy in patients with incurable esophageal and gastroesophageal juncti…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Low-dose Radiation Combined With Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating the combination of low-dose radiation with neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma is…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Immunotherapy Combined With Chemoradiotherapy for First-line Treatment of Esophageal Squamous Cell Carcinoma（ChinECR） [NA]
A ChinECR study is evaluating immunotherapy combined with chemoradiotherapy as first-line treatment for esophageal squamous cell carcinoma. …
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma [Phase 1]
Phase 1 feasibility trial evaluating nivolumab added to neoadjuvant CF or DCF chemotherapy in locally advanced esophageal squamous cell carc…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating nimotuzumab added to definitive chemoradiotherapy in elderly patients with esophageal squamous cell carcin…